Hospital de Clinicas de Porto Alegre UFRGs

Porto Alegre, Rio Grande do Sul 90035-903

1 studies enrolling now · 5 studies all time

What they study most

Arthritis, Rheumatoid, C. Diff Infection, C.Difficile Diarrhea, CDI, Clostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence, Clostridium Difficile, Clostridium Difficile Infection Recurrence, Clostridium Difficile Infections, Diarrhea Infectious, Myelofibrosis, Pancreatic Ductal Carcinoma

Studies at this site

• VE303 for Prevention of Recurrent Clostridioides Difficile Infection — Recruiting now
• A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment — Running, not enrolling
• STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia — Stopped early
• Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis — Completed
• A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma — Stopped early